EyePoint, Inc. (EYPT)
13.10
-0.25
(-1.87%)
USD |
NASDAQ |
May 27, 14:57
EyePoint Cash from Investing (Quarterly) : 59.05M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -4.662M |
| Edgewise Therapeutics, Inc. | 2.433M |
| Merck & Co., Inc. | -10.21B |
| Bristol Myers Squibb Co. | -131.00M |
| Arvinas, Inc. | 13.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -80.55M |
| Cash from Financing (Quarterly) | -2.614M |
| Free Cash Flow | -271.54M |
| Free Cash Flow Per Share (Quarterly) | -0.9482 |
| Free Cash Flow to Equity (Quarterly) | -81.07M |
| Free Cash Flow to Firm (Quarterly) | -81.55M |
| Free Cash Flow Yield | -26.82% |